SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Harnessing B-Cells and Antibodies for HIV Control
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
Session Overview
Nicole A. Doria-Rose
Vaccine Research Center, Bethesda, MD, USA
AAV-Delivered Antibody Reaches Mucosal Sites and Protects Against SHIV Infection in Rhesus Macaques (ABSTRACT
294)
Luanna E. L. Vidal
University of Miami, Miami, FL, USA
Beating the Clock: Timing 10E8.4/iMab Administration to Block SHIV Infection (ABSTRACT
295)
Matthew S. Parsons
Armed Forces Research Institute of Medical Sciences in Bangkok, Bangkok, Thailand
Antigen-Specific Memory B Cells of Extrafollicular Origin May Contribute to ART-Free HIV Control (ABSTRACT
296)
Elif Cakan
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
Evidence of Immune Activation During bNAb-Mediated HIV Suppression Following ATI (ABSTRACT
297)
Julia A. Wagner
University of California San Francisco, San Francisco, CA, USA
Discussion With Audience Questions and Answers
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
